A large number of TCR Vδ1 cells expressed CD16 in HIV+ w/o HL patients and their frequency was higher in cART treated HIV+ w/o HL patients than in HIV+ HL+ patients. This evidence concerns the gene FCGR3A and Hodgkins lymphoma.